Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,934 | 55,070 | 33,038 | 22,351 | 25,890 |
| Marketable Securities | 73,716 | 53,461 | 102,899 | 168,914 | 130,364 |
| Receivables | 4,750 | 2,827 | 9,784 | 4,727 | 4,347 |
| TOTAL | $102,093 | $112,575 | $147,705 | $198,061 | $163,400 |
| Non-Current Assets | |||||
| PPE Net | 11,795 | 14,725 | 15,296 | 13,603 | 5,917 |
| Intangibles | 2,785 | 3,111 | 3,495 | 0 | 0 |
| Other Non-Current Assets | 1,778 | 1,790 | 1,802 | 4,721 | 1,784 |
| TOTAL | $16,358 | $19,626 | $20,593 | $18,324 | $7,701 |
| Total Assets | $118,451 | $132,201 | $168,298 | $216,385 | $171,101 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 17 | 721 | 883 | 845 |
| Accounts payable and accrued liabilities | 4,225 | 5,578 | 9,132 | 4,311 | 3,080 |
| Accrued Expenses | 6,114 | 6,744 | 5,973 | 5,786 | 3,355 |
| Other current liabilities | N/A | 2,000 | 2,000 | N/A | N/A |
| TOTAL | $16,340 | $19,092 | $22,412 | $12,762 | $7,739 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 738 | 1,621 |
| Deferred Revenues | 2,920 | 2,220 | 2,250 | 245 | 175 |
| Other Non-Current Liabilities | 49 | 119 | 180 | 0 | 0 |
| TOTAL | $7,949 | $13,604 | $18,346 | $21,032 | $3,207 |
| Total Liabilities | $24,289 | $32,696 | $40,758 | $33,794 | $10,946 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,839 | 39,885 | 36,759 | 36,319 | 30,501 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -321,049 | -257,037 | -194,400 | -125,519 | -73,606 |
| Other shareholders' equity | -7 | 414 | 332 | 45 | -2,432 |
| TOTAL | $94,162 | $99,505 | $127,540 | $182,591 | $160,155 |
| Total Liabilities And Equity | $118,451 | $132,201 | $168,298 | $216,385 | $171,101 |